← State exam

84. Terminal ileitis, small bowel tumours and Crohn's disease

High yield

Crohn's disease is transmural and patchy; surgery treats complications and saves bowel. Small bowel tumours are rare.

Exam Prep · State examSurgery · General surgerySurgery · ColorectalSurgery · Surgical oncology

1. Definition

  • Terminal ileitis → inflammation of the terminal ileum; causes include Crohn's disease, Yersinia, tuberculosis, backwash ileitis (UC), lymphoma, NSAIDs, Behçet's disease
  • Crohn's disease → chronic, relapsing, transmural granulomatous inflammation that can affect any part of the gut from mouth to anus, with skip lesions; most often the terminal ileum and caecum
  • Small bowel tumours → benign (adenoma, lipoma, leiomyoma, hamartoma, haemangioma) or malignant (neuroendocrine tumour, adenocarcinoma, lymphoma, GIST, metastases)

2. Epidemiology

Crohn's disease

  • Incidence 5–20 per 100,000 a year in Europe and North America; rising in Asia
  • Peak 15–30 years, smaller peak at 50–70
  • Slightly more in women; Ashkenazi Jews; northern Europe; urban areas
  • Smokers have twice the risk (opposite of UC)
  • Distribution:
    • Ileocaecal (ileocolic) about 40–50%
    • Small bowel only about 30%
    • Colon only about 20–25%
    • Perianal disease in about 30%
  • About 70–80% need surgery at some time; 30–50% need a second operation within 10 years (rates now falling with biologics)

Small bowel tumours

  • Small bowel is 75% of the gut length and 90% of its surface, but has only 3–6% of GI tumours and about 2% of GI cancers
  • Neuroendocrine tumours (ileum) and adenocarcinoma (duodenum) are the most common malignancies; then lymphoma and GIST
  • Age 50–70; diagnosis often delayed by months

3. Aetiology and risk factors

Crohn's disease

  • Genetic → family history (10–15%), NOD2/CARD15 mutation (ileal, stricturing), ATG16L1, IL23R
  • Environment → smoking, Western diet, antibiotics in childhood, NSAIDs, oral contraceptives, appendicectomy (debated)
  • Gut microbiota → abnormal immune response to normal bacteria (dysbiosis)
  • Immune → Th1 and Th17 response, TNF-alpha, IL-12, IL-23

Other terminal ileitis

  • Yersinia enterocolitica (acute, children)
  • Ileocaecal tuberculosis (endemic areas, HIV)
  • Backwash ileitis (pancolitis in UC), NSAIDs, radiation, ischaemia, lymphoma, Behçet's, typhoid, actinomycosis, amoebiasis

Small bowel tumours

  • Crohn's disease → adenocarcinoma in strictured ileum
  • Coeliac disease → enteropathy-associated T-cell lymphoma (EATL), adenocarcinoma
  • Familial adenomatous polyposis → duodenal and periampullary adenomas and cancer
  • Lynch syndrome, Peutz-Jeghers syndrome (hamartomas; intussusception)
  • Immunosuppression, HIV → lymphoma, Kaposi's sarcoma
  • Neurofibromatosis type 1 → GIST
  • MEN1 → duodenal gastrinoma

4. Pathogenesis

Crohn's disease

  1. Abnormal immune response in the mucosa
  2. Aphthous ulcers over lymphoid follicles
  3. Deep linear (fissuring) ulcers + oedematous mucosa → "cobblestone" pattern
  4. Transmural inflammation → thick wall, non-caseating granulomas (in 50–60%)
  5. Fat wraps around the bowel → "creeping fat" (fat wrapping)
  6. Chronic inflammation → fibrosis → strictures (string sign of Kantor)
  7. Deep fissures pass through the wall → fistulas, abscesses, adhesions to nearby organs
  8. Three behaviours (Montreal):
    • Inflammatory (non-stricturing, non-penetrating)
    • Stricturing (fibrotic narrowing → obstruction)
    • Penetrating (fistula, abscess, perforation)
  9. Terminal ileum disease → loss of bile salt and vitamin B12 absorption → diarrhoea, gallstones, oxalate kidney stones, B12 deficiency

Small bowel tumours

  • Fewer tumours because of rapid transit, liquid contents, few bacteria, high IgA and lymphoid tissue, alkaline pH, rapid cell turnover
  • Neuroendocrine tumours (carcinoid) → from enterochromaffin cells; ileum; often multiple; desmoplastic reaction in the mesentery → kinking, mesenteric ischaemia; spread to nodes and liver → carcinoid syndrome (serotonin bypasses the liver)
  • Adenocarcinoma → adenoma-carcinoma sequence; duodenum (most common site); annular, obstructing
  • Lymphoma → non-Hodgkin B-cell (MALT, diffuse large B-cell, Burkitt's in the ileocaecal region of children), EATL (coeliac)
  • GIST → interstitial cells of Cajal; KIT (CD117) or PDGFRA; jejunum and ileum; bleed into the lumen
  • Metastases → melanoma (most common metastasis to the small bowel), breast, lung

5. Classification

Montreal classification of Crohn's disease

  • Age (A) → A1 ≤ 16, A2 17–40, A3 > 40
  • Location (L) → L1 ileal, L2 colonic, L3 ileocolonic, L4 upper GI (added)
  • Behaviour (B) → B1 inflammatory, B2 stricturing, B3 penetrating; p = perianal disease

Severity

  • Crohn's Disease Activity Index (CDAI), Harvey-Bradshaw index

Small bowel tumours

  • Benign → adenoma (duodenum), lipoma, leiomyoma, haemangioma, hamartoma (Peutz-Jeghers), Brunner's gland adenoma
  • Malignant → NET, adenocarcinoma, lymphoma, GIST, sarcoma, metastases
Table comparing Crohn's disease and ulcerative colitis
Diagram: Crohn's disease and ulcerative colitis compared

6. Clinical picture

Crohn's disease: symptoms

  • Chronic diarrhoea (often without blood in small bowel disease), abdominal pain (RIF, colicky after meals)
  • Weight loss, fatigue, fever, malaise
  • Children → growth failure, delayed puberty
  • Obstruction (strictures) → colicky pain, distension, vomiting
  • Fistula symptoms → pneumaturia, faecal discharge from the vagina or skin, diarrhoea (enteroenteric)
  • Perianal disease → abscesses, complex fistulas, skin tags, fissures (often atypical, lateral)
  • Acute terminal ileitis may present like appendicitis

Crohn's disease: signs

  • Thin, pale; RIF tenderness or mass (inflamed loops, abscess)
  • Mouth ulcers, perianal skin tags, fistulas
  • Extraintestinal manifestations:
    • Joints → enteropathic arthritis (large joints), sacroiliitis, ankylosing spondylitis
    • Skin → erythema nodosum, pyoderma gangrenosum
    • Eyes → episcleritis, uveitis
    • Liver → primary sclerosing cholangitis (less than in UC), gallstones
    • Kidney → oxalate stones; amyloidosis; VTE; osteoporosis

Small bowel tumours

  • Vague and late → intermittent colicky pain, weight loss, anaemia
  • Obstruction (adenocarcinoma, intussusception from a polyp or lipoma)
  • Occult or overt GI bleeding (GIST, adenoma, metastasis)
  • Duodenal tumours → jaundice, gastric outlet obstruction
  • Perforation (lymphoma)
  • Carcinoid syndrome (only with liver metastases, about 10%) → flushing, diarrhoea, wheeze, right-sided heart disease (tricuspid regurgitation, pulmonary stenosis)

7. Diagnosis

Crohn's disease

  • Bloods → FBC (anaemia, raised platelets), CRP, ESR, albumin, ferritin, B12, folate, vitamin D, LFT, U&E
  • Faecal calprotectin → raised in active inflammation (separates IBD from IBS)
  • Stool cultures, C. difficile toxin (exclude infection)
  • Ileocolonoscopy with biopsies → first-line: aphthous ulcers, skip lesions, cobblestoning, rectal sparing, non-caseating granulomas on histology
  • MR enterography → small bowel extent, strictures, fistulas, active vs fibrotic disease (no radiation)
  • Pelvic MRI → perianal fistulas and abscesses
  • CT → acute complications (abscess, perforation, obstruction)
  • Intestinal ultrasound → wall thickness, follow-up
  • Capsule endoscopy → small bowel disease without stricture (patency capsule first)
  • Upper GI endoscopy → upper GI disease
  • Barium follow-through (historical) → string sign of Kantor, fistulas, cobblestone
  • TB → IGRA, chest X-ray, biopsy culture and PCR (TB mimics Crohn's; do not start biologics before excluding TB)

Small bowel tumours

  • CT enterography or MR enterography → mass, wall thickening, obstruction
  • Capsule endoscopy → obscure bleeding
  • Double-balloon enteroscopy → biopsy, tattoo, polypectomy
  • Upper GI endoscopy → duodenal tumours
  • NET → 24-hour urine 5-HIAA, chromogranin A, Ga-68 DOTATATE PET-CT, echocardiography (carcinoid heart disease)
  • GIST → CT, biopsy (CD117, DOG1)
  • Lymphoma → biopsy, PET-CT, bone marrow
  • Diagnosis often made at laparotomy for obstruction or bleeding

8. Differential diagnosis

  • Acute appendicitis, appendix mass
  • Ulcerative colitis (colonic Crohn's)
  • Ileocaecal tuberculosis (caseating granulomas, endemic area)
  • Yersinia ileitis, infectious colitis (Campylobacter, Salmonella, C. difficile)
  • Lymphoma, caecal carcinoma, small bowel tumours
  • Irritable bowel syndrome
  • Coeliac disease, NSAID enteropathy, radiation enteritis, ischaemic colitis
  • Behçet's disease

9. Treatment

Conservative: Crohn's disease

  • Stop smoking (halves relapse)
  • Induction of remission:
    • Corticosteroids → prednisolone (moderate to severe), budesonide (mild to moderate ileocaecal disease)
    • Exclusive enteral nutrition → first-line in children
    • Biologics → anti-TNF (infliximab, adalimumab), vedolizumab (anti-integrin), ustekinumab, risankizumab (anti-IL-23)
    • JAK inhibitors (upadacitinib)
    • IV steroids for acute severe disease
  • Maintenance of remission:
    • Thiopurines (azathioprine, mercaptopurine; check TPMT first) or methotrexate
    • Biologics (often combined with a thiopurine)
    • Steroids are not for maintenance
  • 5-ASA (mesalazine) → little benefit in Crohn's (unlike UC)
  • Perianal fistula → seton drainage plus anti-TNF (infliximab); antibiotics (metronidazole, ciprofloxacin)
  • Abscess → antibiotics + percutaneous drainage, then medical therapy or elective surgery
  • Short strictures (under 5 cm, no fistula) → endoscopic balloon dilatation
  • Nutrition → B12 injections, iron, vitamin D, calcium; dietitian
  • Before surgery → optimise nutrition (enteral or parenteral), reduce steroids (more complications if prednisolone over 20 mg), drain sepsis first

Surgical: Crohn's disease

  • Principles:
    • Surgery does not cure Crohn's disease; it treats complications and disease not responding to drugs
    • Save bowel → resect only macroscopic disease with 2 cm margins; microscopic clear margins do not lower recurrence
    • Avoid short bowel syndrome
    • Early ileocaecal resection is an alternative to biologics in limited terminal ileal disease (LIRIC trial)
  • Indications:
    • Failure of medical therapy, steroid dependence, drug side effects
    • Obstruction from fibrotic strictures
    • Fistulas (enterovesical, enterocutaneous, symptomatic enteroenteric) and abscesses
    • Perforation, severe bleeding
    • Toxic colitis (colonic Crohn's)
    • Dysplasia or cancer
    • Growth failure in children
  • Operations:
    • Ileocaecal resection (limited right hemicolectomy) → most common operation for terminal ileal disease; laparoscopic preferred; side-to-side stapled or Kono-S anastomosis (fewer recurrences)
    • Segmental small bowel resection with anastomosis
    • Stricturoplasty → for multiple short strictures or previous resections (saves bowel):
      • Heineke-Mikulicz → strictures under 10 cm: longitudinal incision, transverse closure
      • Finney → strictures 10–25 cm
      • Michelassi (side-to-side isoperistaltic) → long strictures
      • Not for strictures with fistula, abscess, phlegmon or suspicion of cancer
    • Fistula → resect the diseased bowel; repair the healthy organ (bladder, sigmoid) simply
    • Colonic Crohn's → segmental colectomy, subtotal colectomy with end ileostomy, or proctocolectomy with end ileostomy (no ileal pouch in Crohn's: high failure)
    • Diverting ileostomy → severe perianal disease
    • Emergency → resection with stoma if septic, malnourished or on high-dose steroids (avoid anastomosis)
  • Postoperative → stop smoking; colonoscopy at 6–12 months (Rutgeerts score); start biologic or thiopurine in high-risk patients (POCER trial)

Treatment: small bowel tumours

  • Adenocarcinoma → segmental resection with mesentery and nodes; duodenal → pancreaticoduodenectomy (Whipple) or segmental duodenal resection; adjuvant chemotherapy (FOLFOX or CAPOX) for node-positive disease
  • NET → resection with mesenteric lymphadenectomy (nodes often large); palpate the whole small bowel (multiple tumours); cholecystectomy if somatostatin analogues are planned; liver metastases → resection, ablation, somatostatin analogues, PRRT (lutetium-177)
    • Octreotide cover before surgery in carcinoid syndrome (prevents carcinoid crisis)
  • GIST → segmental resection with clear margins, no lymphadenectomy, avoid rupture; imatinib adjuvant (high risk) or for metastatic disease
  • Lymphoma → chemotherapy (R-CHOP); surgery for obstruction, perforation, bleeding or diagnosis
  • Benign tumours → endoscopic or surgical resection if symptomatic (bleeding, intussusception)
  • Peutz-Jeghers → enteroscopic polypectomy; surgery for intussusception
  • Metastases (melanoma) → palliative resection for bleeding or obstruction
Flowchart of surgery in Crohn's disease
Diagram: when and how to operate in Crohn's disease

10. Complications

Crohn's disease

  • Strictures and obstruction
  • Fistulas (enteroenteric, enterovesical, enterocutaneous, perianal), abscesses
  • Perforation, bleeding, toxic megacolon (colonic)
  • Malnutrition, B12 deficiency, anaemia, osteoporosis, growth failure
  • Gallstones (loss of bile salts) and oxalate kidney stones
  • Short bowel syndrome (after many resections)
  • Cancer → small bowel adenocarcinoma, colorectal cancer (long-standing colitis), anal and fistula cancer; lymphoma (thiopurines)
  • Drug complications → infections and TB (biologics), bone marrow suppression and pancreatitis (thiopurines)
  • Recurrence after resection → endoscopic in 70–90% at 1 year; clinical 20–30% at 1 year; usually at the neoterminal ileum (just above the anastomosis)
  • Surgery → anastomotic leak, intra-abdominal abscess, enterocutaneous fistula, adhesions

Small bowel tumours

  • Obstruction, intussusception, bleeding, perforation
  • Carcinoid syndrome, carcinoid crisis, carcinoid heart disease
  • Mesenteric fibrosis and ischaemia (NET)
  • Late diagnosis → poor survival for adenocarcinoma (5-year survival about 30%)

Mind map Pinch or scroll to zoom · drag to move

Show as a list

Crohn's and small bowel tumours

  • Crohn's
    • Mouth to anus
    • Transmural
    • Skip lesions
    • Granulomas
    • Smoking
  • Montreal
    • L1 ileal, L2 colon, L3 both
    • B1 inflammatory
    • B2 stricturing
    • B3 penetrating
  • Tests
    • Calprotectin
    • Ileocolonoscopy
    • MR enterography
    • Pelvic MRI
  • Medical
    • Steroids: induction
    • Thiopurines: maintenance
    • Anti-TNF, vedolizumab
    • Stop smoking
  • Surgery
    • Complications only
    • Ileocaecal resection
    • Stricturoplasty
    • Save bowel
    • No pouch
  • Small bowel tumours
    • NET: ileum, 5-HIAA
    • Adenocarcinoma: duodenum
    • Lymphoma
    • GIST: imatinib
    • Melanoma metastases

More in State exam